Matches in Nanopublications for { ?s ?p "[Perfusion with the ATP-sensitive K(+) channel (K(ATP)) inhibitor glibenclamide (GLIB) or the mitochondrial K(ATP) (mitoK(ATP)) inhibitor 5-hydroxydecanoate (5-HD) for 20 minutes before ischemia abolishes the cardioprotective effects of CYP2J2 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP968121.RAujj0WtWt2MlEMdMFPq4Q1_tz5w3mqJYCwW5V6T6YNxY130_assertion description "[Perfusion with the ATP-sensitive K(+) channel (K(ATP)) inhibitor glibenclamide (GLIB) or the mitochondrial K(ATP) (mitoK(ATP)) inhibitor 5-hydroxydecanoate (5-HD) for 20 minutes before ischemia abolishes the cardioprotective effects of CYP2J2 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP968121.RAujj0WtWt2MlEMdMFPq4Q1_tz5w3mqJYCwW5V6T6YNxY130_provenance.
- NP452201.RAto6ZDiuWguPJgdYweP3jLflHgNOMnLtFjiwpt6cBcok130_assertion description "[Perfusion with the ATP-sensitive K(+) channel (K(ATP)) inhibitor glibenclamide (GLIB) or the mitochondrial K(ATP) (mitoK(ATP)) inhibitor 5-hydroxydecanoate (5-HD) for 20 minutes before ischemia abolishes the cardioprotective effects of CYP2J2 overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP452201.RAto6ZDiuWguPJgdYweP3jLflHgNOMnLtFjiwpt6cBcok130_provenance.